In smokers with COPD, Knobloch’s research revealed that interferon-γ release from ex vivo generated CD4+ effector cells of the Th1 subtype upon challenge with lipopolysaccharide (LPS) purified from Salmonella minnesota would decrease28. Here, CD4 is linked to chronic obstructive pulmonary disease.